Home › Funds › Jones Hill Capital LP › XENE

Jones Hill Capital LP position in XENE

XENON PHARMACEUTICALS INC · Health Care

Jones Hill Capital LP reported holding 367,900 shares of XENE (XENON PHARMACEUTICALS INC) in its Q2 2026 13F filing — a position valued at US$22.2M, representing 4.72% of its reported portfolio and ranking #9 among its reported holdings. Jones Hill Capital LP first reported this position in Q2 2026.

Latest position (Q2 2026)367.90K sh
Reported value held$22.21M
Portfolio Weight4.72%
First reportedQ2 2026
Last changeNew
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How Jones Hill Capital LP's XENE position evolved

Jones Hill Capital LP first disclosed a stake in XENE in Q2 2026 at 367,900 shares (US$22.2M).

Quarter by quarter

QuarterSharesValueChange
Q2 2026 367.90K $22.21M New

About XENE and 13F data

XENE (XENON PHARMACEUTICALS INC) is a Health Care company. 44 other funds we track also report a position in XENE — the largest reported positions include Avoro Capital Advisors LLC (US$348.7M), Polar Capital Holdings Plc (US$275.9M), DRIEHAUS CAPITAL MANAGEMENT LLC (US$266.7M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding XENE

All XENE fund holders →

FAQ

How long has Jones Hill Capital LP held XENE?

Jones Hill Capital LP has disclosed XENE holdings in 1 of the last 1 reported quarters, going back to Q2 2026.

What is Jones Hill Capital LP's current position in XENE?

As of Q2 2026, Jones Hill Capital LP holds 367.90K shares of XENE (XENON PHARMACEUTICALS INC), valued at $22.21M, representing 4.72% of its reported portfolio and ranking #9.

Has Jones Hill Capital LP been buying or selling XENE?

In the latest 13F filing (Q2 2026), Jones Hill Capital LP newly opened its position in XENE.

Which other funds hold XENE?

Other major institutional holders of XENE include Avoro Capital Advisors LLC, Polar Capital Holdings Plc, DRIEHAUS CAPITAL MANAGEMENT LLC, among 44 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.